Matthew McBride

Apr 18, 2023 | ipwatchdog.com | Amy Fix |John Cleveland |Matthew McBride |Gene Quinn

« All Events - 1:00 pm EDT Free The process for developing new biotech therapies can easily put R&D and intellectual property leaders in uncharted territory. From lead selection to freedom to operate, it is not unusual to request a dozen patent and scientific literature searches to help guide researchers as they attempt to maximize value and opportunity.